Ffisayil 2 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ffisayil 2. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ffisayil 2 Today - Breaking & Trending Today

Spesolimab meets primary and key secondary endpoint for prevention of generalized pustular psoriasis flares

Published: January 30, 2023

EFFISAYIL™ 2 met its primary and key secondary endpoint, demonstrating that spesolimab, an anti-interleukin-36 receptor antibody, can prevent flares in adolescents and adults with generalized pustular psoriasis (GPP) up to 48 weeks.1,2

Source: businesswireindia.com

Related Topics:

Rheinland PfalzLaura LessenichCarinne BrouillonEuropean UnionCorporate CommunicationsBoehringer IngelheimManaging DirectorsHuman PharmaMainland ChinaMedia ContactFfisayil 2Generalized Pustular PsoriasisClinical TrialsCarinne BrouillonHuman PharmaRare Skin DiseasePlaque PsoriasisGpp FlaresNterleukin 36 ReceptorIl 36Ffisayil 1Ffisayil On